Clinical Trial Update: Effect of Body Mass Index on the Dose of Intrathecal Hyperbaric Bupivacaine for Elective Cesarean Section [NA]

View source ↗

Summary

A completed clinical trial investigated how body mass index influences the dose of intrathecal hyperbaric bupivacaine used for elective cesarean section.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• Hyperbaric Bupivacaine (bupivacaine)

Snippet

Sponsor: Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Conditions: Pain, Obesity | NA | Status: COMPLETED